SG11201502649WA - Methods for enhancing the effect of egcg on mitigating skeletal muscle loss - Google Patents
Methods for enhancing the effect of egcg on mitigating skeletal muscle lossInfo
- Publication number
- SG11201502649WA SG11201502649WA SG11201502649WA SG11201502649WA SG11201502649WA SG 11201502649W A SG11201502649W A SG 11201502649WA SG 11201502649W A SG11201502649W A SG 11201502649WA SG 11201502649W A SG11201502649W A SG 11201502649WA SG 11201502649W A SG11201502649W A SG 11201502649WA
- Authority
- SG
- Singapore
- Prior art keywords
- egcg
- enhancing
- methods
- effect
- skeletal muscle
- Prior art date
Links
- 230000000694 effects Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000000116 mitigating effect Effects 0.000 title 1
- 210000002027 skeletal muscle Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pediatric Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261709682P | 2012-10-04 | 2012-10-04 | |
PCT/US2013/063519 WO2014055905A1 (en) | 2012-10-04 | 2013-10-04 | Methods for enhancing the effect of egcg on mitigating skeletal muscle loss |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502649WA true SG11201502649WA (en) | 2015-05-28 |
Family
ID=49354981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502649WA SG11201502649WA (en) | 2012-10-04 | 2013-10-04 | Methods for enhancing the effect of egcg on mitigating skeletal muscle loss |
Country Status (12)
Country | Link |
---|---|
US (2) | US9579347B2 (en) |
EP (1) | EP2903458B1 (en) |
JP (1) | JP2015532104A (en) |
CN (2) | CN104837369B (en) |
BR (1) | BR112015007131A2 (en) |
CA (1) | CA2885388C (en) |
ES (1) | ES2694426T3 (en) |
HK (1) | HK1212560A1 (en) |
MX (1) | MX367861B (en) |
PH (1) | PH12015500756A1 (en) |
SG (1) | SG11201502649WA (en) |
WO (1) | WO2014055905A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9844531B2 (en) | 2013-03-15 | 2017-12-19 | Abbott Laboratories | Methods of maintaining and improving muscle function |
WO2016044272A1 (en) * | 2014-09-16 | 2016-03-24 | Abbott Laboratories | Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract |
NL2015032B1 (en) * | 2015-06-26 | 2017-01-24 | Vitalnext B V | Compositions and methods for the treatment of malnutrition. |
WO2017075289A1 (en) | 2015-10-27 | 2017-05-04 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
CN105901335A (en) * | 2016-05-25 | 2016-08-31 | 中国农业大学 | Feed additive for promoting growth of porcine skeletal muscle and application thereof |
US10485502B2 (en) * | 2016-12-20 | 2019-11-26 | General Electric Company | System and method for assessing muscle function of a patient |
WO2018183251A1 (en) | 2017-03-31 | 2018-10-04 | Abbott Laboratories | Liquid nutritional compositions containing oxidizable fish oil, rosmarinic acid and ferric iron |
JP7198749B2 (en) * | 2017-06-01 | 2023-01-04 | 株式会社明治 | nutritional composition |
US20200163370A1 (en) | 2017-08-03 | 2020-05-28 | Abbott Laboratories | Liquid nutritional compositions including green tea extract and iron |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
CN108094772A (en) * | 2017-12-08 | 2018-06-01 | 桂林莱茵生物科技股份有限公司 | A kind of grosvenor momordica fruit juice and preparation method thereof |
EP3755319A4 (en) * | 2018-02-20 | 2021-12-01 | Epirium Bio Inc. | Compounds and compositions for the treatment of muscular disorders |
KR102240426B1 (en) * | 2018-11-30 | 2021-04-14 | 재단법인 하동녹차연구소 | Manufacturing extract method of melanian snail and green tea and melanian snail extract thereof |
KR102216599B1 (en) * | 2018-11-30 | 2021-02-16 | (주)정옥 | Manufacturing extract powder method of melanian snail and green tea for sarcopenia improvement and melanian snail extract powder for sarcopenia improvement thereof |
CN111000233A (en) * | 2019-11-28 | 2020-04-14 | 湖南农业大学 | Application of ECG as muscle building functional component |
JP7407643B2 (en) * | 2020-04-02 | 2024-01-04 | サントリーホールディングス株式会社 | Heat-sterilized packaged beverage containing medium-chain fatty acid triglyceride and ascorbic acid |
WO2022165263A1 (en) * | 2021-01-29 | 2022-08-04 | Uqora, Inc. | Compositions and methods for treating bacterial infections |
CN117651496A (en) * | 2021-06-17 | 2024-03-05 | 优鲜沛蔓越莓公司 | Rare sugars in food and beverage products |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455059A (en) * | 1993-10-15 | 1995-10-03 | Nabisco, Inc. | Fat-free toppings and fillings for bakery products |
IT1299197B1 (en) | 1998-06-30 | 2000-02-29 | Sigma Tau Healthscience Spa | COMPOSITION WITH ANTI-OXIDANT, ANTIPOLIFERATIVE, ENERGETIC ACTIVITY AND SUITABLE TO IMPROVE THE METABOLIC USE OF GLUCOSE. |
US6509054B1 (en) * | 2000-05-05 | 2003-01-21 | American Fruits And Flavors | Food additives having enlarged concentration of phenolics extracted from fruits, and process of obtaining the same |
US20020122835A1 (en) | 2001-03-01 | 2002-09-05 | Bucci Luke R. | Compositions for enhancing muscle tissue recovery and repair |
US7026298B2 (en) | 2001-06-04 | 2006-04-11 | Abbott Laboratories | Oral rehydration compositions |
WO2003011339A1 (en) | 2001-07-30 | 2003-02-13 | Dsm Ip Assets B.V. | Composition for epigallocatechin gallate |
EP1638407A1 (en) | 2003-07-03 | 2006-03-29 | The Procter & Gamble Company | Compositions containing green tea catechins and one or more polyvalent mineral cations |
FR2861594B1 (en) | 2003-11-03 | 2006-01-20 | Baudry Jacquet | COMPOSITION CONTAINING EXTRACT OF GREEN AND VITAMIN C |
NZ550929A (en) | 2004-05-07 | 2009-09-25 | Thermo Formulations Ltd | Nutritional composition for increasing creative uptake in skeletal muscle |
WO2005110122A1 (en) * | 2004-05-18 | 2005-11-24 | Dsm Ip Assets B.V. | USE OF β-CRYPTOXANTHIN |
US20050260302A1 (en) * | 2004-05-19 | 2005-11-24 | The Procter & Gamble Company | Nutritionally balanced traditional snack foods having a low glycemic response |
US20060188548A1 (en) | 2004-12-14 | 2006-08-24 | Mattson Peter H | Satiety promoting beverage and use in a diet to moderate food consumption |
JP2006188436A (en) | 2004-12-28 | 2006-07-20 | Japan Science & Technology Agency | Medical polyphenol solution |
FR2882896B1 (en) | 2005-03-14 | 2007-05-04 | Larena Sa | FOOD COMPOSITION FOR PREVENTING FRAGILITY SYNDROME IN OLDER PEOPLE |
WO2006116452A1 (en) | 2005-04-22 | 2006-11-02 | Molecular Regenix, Llc | Nutritional composition comprising hyaluronic acid and superoxide dismutase and methods of making and using same |
WO2007006135A1 (en) | 2005-07-07 | 2007-01-18 | H3 Formulations Ltd. | Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
CN100435790C (en) * | 2005-09-05 | 2008-11-26 | 中山大学 | EGCG-zinc complex solid dispersion, its preparation method and application |
ATE537819T1 (en) * | 2005-10-14 | 2012-01-15 | Dsm Ip Assets Bv | NUTRACEUTICAL COMPOSITIONS FOR TREATING MUSCLE WASTING |
CN101312718A (en) * | 2005-10-14 | 2008-11-26 | 帝斯曼知识产权资产管理有限公司 | Nutraceutical composition for the treatment of muscle wasting |
KR20090037404A (en) | 2006-07-05 | 2009-04-15 | 카오카부시키가이샤 | Agent for improving muscle power |
JP2008013473A (en) * | 2006-07-05 | 2008-01-24 | Kao Corp | Muscle hypofunction inhibitor |
US8962678B2 (en) * | 2006-07-05 | 2015-02-24 | Kao Corporation | Senescence inhibitor |
ITMI20061854A1 (en) | 2006-09-28 | 2008-03-29 | Genalta S R L | BEVERAGE SUITED TO SLOW DOWN CELL DEGENERATION THAT ACCOMPANIES AGING |
EP1961310A1 (en) * | 2007-02-01 | 2008-08-27 | DSMIP Assets B.V. | Novel use of (-) -epigallocatechin gallate |
US20080193601A1 (en) | 2007-02-10 | 2008-08-14 | Nasser Faik A | Protein-containing beverage and method of manufacture |
US20080233245A1 (en) | 2007-03-19 | 2008-09-25 | Lesley Joan White | Liquid nutrient composition for improving performance |
US7989007B2 (en) | 2007-07-03 | 2011-08-02 | Vincent James Enterprises, Llc | Weight loss composition |
CN101778572A (en) | 2007-08-02 | 2010-07-14 | 荷兰联合利华有限公司 | compositions comprising polyphenol |
US20100129467A9 (en) | 2007-08-31 | 2010-05-27 | Albritton Iv Ford D | Nutritional supplement |
US20090176312A1 (en) * | 2007-12-04 | 2009-07-09 | Selinfreund Richard H | Biological and chemical test media and system |
CA2649477C (en) | 2008-04-18 | 2016-04-19 | Nuvocare Health Sciences Inc. | Composition and method for promoting internal health and external appearance |
DK2381784T3 (en) * | 2008-12-09 | 2018-10-22 | Metabolic Tech Inc | Nutritional intervention to improve muscle function and strength |
AU2010274125B2 (en) * | 2009-07-20 | 2015-11-05 | Société des Produits Nestlé S.A. | Methods of attenuating the loss of functional status |
WO2011078654A1 (en) * | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
JP2013126951A (en) * | 2010-03-01 | 2013-06-27 | Kyushu Univ | Muscular atrophy inhibitor |
JP2011225475A (en) * | 2010-04-16 | 2011-11-10 | Celeste Inter Cooperation | Muscle atrophy inhibitor and muscle growth promoter |
TWI526161B (en) | 2010-06-10 | 2016-03-21 | 亞培公司 | Substantially clear nutritional liquids comprising calcium hmb and soluble protein |
EP2584920B1 (en) | 2010-06-28 | 2017-12-13 | Nestec S.A. | Hypocaloric, high protein nutritional compositions and methods of using same |
WO2012097061A1 (en) | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for improving skeletal muscle protein metabolism |
JP5438784B2 (en) * | 2011-02-10 | 2014-03-12 | ロート製薬株式会社 | Muscle atrophy inhibitor and muscle growth promoter |
JP2012180331A (en) * | 2011-03-03 | 2012-09-20 | Meiji Co Ltd | Oral ingestion medicine for inducement of early recovery of muscle damage |
CN102224953B (en) * | 2011-04-27 | 2012-10-17 | 陈石良 | Breast enhancing health care beverage |
-
2013
- 2013-10-04 SG SG11201502649WA patent/SG11201502649WA/en unknown
- 2013-10-04 CN CN201380051027.7A patent/CN104837369B/en not_active Expired - Fee Related
- 2013-10-04 CN CN201710015527.5A patent/CN107048383A/en active Pending
- 2013-10-04 BR BR112015007131A patent/BR112015007131A2/en not_active IP Right Cessation
- 2013-10-04 ES ES13776697.8T patent/ES2694426T3/en active Active
- 2013-10-04 EP EP13776697.8A patent/EP2903458B1/en active Active
- 2013-10-04 JP JP2015535831A patent/JP2015532104A/en active Pending
- 2013-10-04 US US14/433,538 patent/US9579347B2/en active Active
- 2013-10-04 WO PCT/US2013/063519 patent/WO2014055905A1/en active Application Filing
- 2013-10-04 CA CA2885388A patent/CA2885388C/en not_active Expired - Fee Related
- 2013-10-04 MX MX2015004181A patent/MX367861B/en active IP Right Grant
-
2015
- 2015-04-06 PH PH12015500756A patent/PH12015500756A1/en unknown
-
2016
- 2016-01-18 HK HK16100500.5A patent/HK1212560A1/en not_active IP Right Cessation
-
2017
- 2017-02-24 US US15/441,658 patent/US20170165297A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150265650A1 (en) | 2015-09-24 |
HK1212560A1 (en) | 2016-06-17 |
MX367861B (en) | 2019-09-09 |
WO2014055905A1 (en) | 2014-04-10 |
US20170165297A1 (en) | 2017-06-15 |
CA2885388A1 (en) | 2014-04-10 |
CA2885388C (en) | 2018-01-02 |
CN107048383A (en) | 2017-08-18 |
JP2015532104A (en) | 2015-11-09 |
US9579347B2 (en) | 2017-02-28 |
PH12015500756A1 (en) | 2015-05-25 |
MX2015004181A (en) | 2015-06-10 |
EP2903458A1 (en) | 2015-08-12 |
CN104837369A (en) | 2015-08-12 |
EP2903458B1 (en) | 2018-09-05 |
ES2694426T3 (en) | 2018-12-20 |
BR112015007131A2 (en) | 2017-07-04 |
CN104837369B (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212560A1 (en) | Methods for enhancing the effect of egcg on mitigating skeletal muscle loss egcg | |
HK1208363A1 (en) | New methods | |
EP2916680A4 (en) | Devices and methods for adjusting the fit of footwear | |
EP2916795A4 (en) | Improved rollator | |
EP2836211A4 (en) | Novel methods | |
EP2835265A4 (en) | Image-forming method | |
EP2842761A4 (en) | Image-forming method | |
EP2934211A4 (en) | Heel-suspending protective boot | |
GB2506114B (en) | Boot | |
HRP20190038T1 (en) | Pantothenate derivatives for the treatment of neurologic disorders | |
EP2874700A4 (en) | Multiscale spectral nanoscopy | |
HK1200109A1 (en) | Ophthalmic composition | |
HK1208817A1 (en) | Chromane compounds | |
HK1200113A1 (en) | Ophthalmic composition | |
EP2894215A4 (en) | Fat composition | |
PL2805796T3 (en) | Grinding method | |
GB2503737B (en) | Carabiner | |
EP2861586A4 (en) | Forms of vilazodone and processes for the preparation thereof | |
EP2933273A4 (en) | Polymerizable composition | |
EP2800573A4 (en) | Ophthalmic composition | |
IL233477B (en) | Ophthalmic composition | |
GB201219053D0 (en) | Aleshba's oil | |
GB201206124D0 (en) | Match my fit | |
GB201214234D0 (en) | Prophylactic therapy | |
TWM433571U (en) | Detachable eyeglasses |